NYSE$DVA

DaVita HealthCare Partners Inc · Q4 2023 earnings

Q4 2023 earnings · · Investor relations

Briefing

DaVita's financial performance in Q4 2023 showcased the resilience of its business, overcoming external challenges and positioning the company for future growth through strategic investments.

DaVita Inc. reported consolidated revenues of $3.146 billion for Q4 2023. Operating income was $390 million, with adjusted operating income at $415 million. Diluted earnings per share from continuing operations was $1.62, and adjusted diluted earnings per share was $1.87. The company repurchased 2,903,832 shares of its common stock at an average price of $97.82 per share during the quarter.

  • Consolidated revenues reached $3.146 billion.
  • Operating income was reported at $390 million, with an adjusted figure of $415 million.
  • Diluted EPS from continuing operations was $1.62, while adjusted diluted EPS was $1.87.
  • The company repurchased 2,903,832 shares for $286 million, at an average price of $97.82 per share.

Headline financials

Total Revenue

$3.15B

Previous: $2.92B+7.8%
EPS (adj)

$1.87

Previous: $1.11+68.5%
Capital Expenditures

-$159M

Previous: $194M-181.9%
Free Cash Flow

$258M

Previous: $75M+244.0%
Net Income

$231M

Previous: $127M+82.1%
Operating Income

$390M

Previous: $256M+52.3%
Gross Profit

$812M

Previous: $828M-1.9%
Stock-Based Comp

$30.1M

Previous: $17.5M+71.6%

Revenue & EPS history

DaVita · Revenue · Quarterly

$3.15B

Q4 2023+7.8%vs Q4 2022
Beat estimate in 9 of 15 quarters(60%)
ActualEstimate

Revenue by segment

DaVita · $3.14B total across 3 segments · Q3 2023

  • U.S. Dialysis Patient Services
    $2.79B+3.0%
  • International Dialysis Patient Service
    $200M+14.3%
  • Integrated Kidney Care
    $158M+81.6%

Forward guidance

DaVita provided its 2024 financial outlook, with adjusted operating income expected to be between $1.825 billion and $1.975 billion, adjusted diluted net income per share attributable to DaVita Inc. between $8.70 and $9.80, and free cash flow between $900 million and $1.150 billion.

Tailwinds

  • Adjusted operating income is projected to be between $1.825 billion and $1.975 billion.
  • Adjusted diluted net income per share is expected to range from $8.70 to $9.80.
  • Free cash flow is anticipated to be between $900 million and $1.150 billion.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2023

Historical avgQ4 2023

+0.2%

Avg return

Earnings day

+0.5%

Avg return

5 days after

+1.6%

Avg return

30 days after

54%

39 / 72 earnings

Positive

+14.7%

Q3 2019

Best reaction

-24.5%

Q3 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.6%+22.2%+22.4%
Q4 2025+11.0%+26.7%+34.9%
Q3 2025-6.0%-5.2%-5.4%
Q1 2025-0.2%+0.7%-4.9%
Q4 2024-11.1%-12.5%-19.0%
Q3 2024-10.1%-9.8%+5.5%
Q2 2024-1.1%+3.6%+9.8%
Q1 2024-3.8%-1.5%+5.3%
Q4 2023+8.0%+6.9%+19.0%
Q3 2023+7.4%+5.1%+33.9%
Q2 2023+6.7%+8.6%+1.0%
Q1 2023+13.8%+5.9%+13.7%
Q4 2022-0.3%-0.3%-8.4%
Q3 2022-24.5%-27.9%-23.6%
Q2 2022+2.7%+1.8%+1.3%
Q1 2022-7.1%-5.0%-12.7%
Q4 2021-1.2%+3.5%-2.6%
Q3 2021-6.9%-6.2%-12.3%
Q2 2021+10.2%+9.7%+10.0%
Q1 2021+2.8%+8.9%+6.0%
Q4 2020-7.4%-8.1%-4.4%
Q3 2020-0.0%+7.7%+27.4%
Q2 2020-4.3%-8.5%-4.8%
Q1 2020+9.6%+7.5%+9.7%
Q4 2019+8.8%+5.7%-8.0%
Q3 2019+14.7%+13.6%+17.9%
Q2 2019+0.4%-1.5%-5.8%
Q1 2019-10.4%-9.8%-19.4%
Q4 2018+1.3%+3.0%-6.7%
Q3 2018+1.3%-1.5%-14.9%
Q2 2018+5.4%+3.9%-1.4%
Q1 2018+4.7%+1.2%+5.9%
Q4 2017+1.8%+0.3%-5.4%
Q3 2017-8.5%-7.4%+13.0%
Q2 2017-9.8%-10.9%-9.6%
Q1 2017-3.8%-5.3%-2.4%
Q4 2016+3.2%+6.2%+4.5%
Q3 2016+1.1%+0.1%+11.1%
Q2 2016-6.0%-10.1%-16.4%
Q1 2016+2.9%
Q4 2015-1.7%
Q3 2015-0.9%
Q2 2015+1.0%
Q1 2015-1.1%
Q4 2014-3.8%
Q3 2014-3.9%
Q2 2014+0.1%
Q1 2014-2.8%
Q4 2013+3.9%
Q3 2013-3.0%
Q2 2013-2.9%
Q1 2013+9.4%
Q4 2012-1.1%
Q3 2012+1.4%
Q2 2012-1.1%
Q1 2012-4.9%
Q4 2011+0.3%
Q3 2011+0.8%
Q2 2011-0.2%
Q1 2011+2.9%
Q4 2010+2.4%
Q3 2010-0.4%
Q2 2010+3.3%
Q1 2009+1.1%
Q1 2010+0.3%
Q4 2009-0.1%
Q3 2009+0.1%
Q3 2008+0.1%
Q2 2008+4.6%
Q4 2008+4.6%
Q2 2009+4.6%
Q4 2007+4.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro